Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters ; volume:10 ; number:1 ; day:18 ; month:6 ; year:2019 ; pages:1-11 ; date:12.2019
Nature Communications ; 10, Heft 1 (18.6.2019), 1-11, 12.2019
- Urheber
-
Lee, Yong Gu
Chu, Haiyan
Lu, Yingjuan
Leamon, Christopher P.
Srinivasarao, Madduri
Putt, Karson S.
Low, Philip S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-10565-7
- URN
-
urn:nbn:de:101:1-2019090609534160154491
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Yong Gu
- Chu, Haiyan
- Lu, Yingjuan
- Leamon, Christopher P.
- Srinivasarao, Madduri
- Putt, Karson S.
- Low, Philip S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytokine release syndrome
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Cytokine release syndrome: grading, modeling, and new therapy
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
Cytokine release syndrome
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Cytokine release syndrome: grading, modeling, and new therapy
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
In vivo generation of human CD19‐CAR T cells results in B‐cell depletion and signs of cytokine release syndrome
Cytokine release syndrome
Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Cytokine release syndrome after bronchoalveolar lavage
Targeting CDK7 suppresses super enhancer-linked inflammatory genes and alleviates CAR T cell-induced cytokine release syndrome
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Cytokine release syndrome: grading, modeling, and new therapy
Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies